These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 47798)

  • 41. An immuno-haematological study among pregnant women of Patiala (India).
    Bhatnagar DP; Sidhu LS; Bhutani B
    Anthropol Anz; 1979 Jan; 37(1):10-7. PubMed ID: 109034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rh immunisation and its prevention.
    Woodrow JC
    Ser Haematol; 1970; 3(3):1-151. PubMed ID: 4109155
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cytotoxic anti-HL-A antibodies in a case of hydatid mole during 1st gestation].
    Turowski G; Sowiński S; Zdebski Z
    Ginekol Pol; 1973 Feb; 44(2):169-71. PubMed ID: 4632031
    [No Abstract]   [Full Text] [Related]  

  • 45. Relationship between human serum placental alkaline phosphatase and the ABo and Rh compatibility status in pregnancy.
    Lucarelli P; Scacchi R; Corbo RM; Pascone R; Carapella E; Palmarino R
    Biol Res Pregnancy Perinatol; 1985; 6(2):89-93. PubMed ID: 3926009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Frequency and significance of leucocyte iso-antibodies in women with Rh-incompatibility (author's transl)A1].
    Hübel E; Bertrams J; Kuwert E; Luboldt W; Fischer K
    Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):411-8. PubMed ID: 4282923
    [No Abstract]   [Full Text] [Related]  

  • 47. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
    Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract]   [Full Text] [Related]  

  • 48. [Fetomaternal immunization of pregnant women to HL-A alloantigens and ABO and Rh antigens. II. Clinical observations on the course of pregnancy].
    Zdebski Z
    Folia Med Cracov; 1974; 16(3):341-53. PubMed ID: 4212657
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hemolytic disease of the newborn caused by fetomaternal incompatibility].
    Escandé CA; Lorenzo y de Ibarreta J; Temesio N; Garófalo O; Pérez-Scremini A; Vila-Vidal P; Vilanova R
    Arch Pediatr Urug; 1965 Jul; 36(7):455-68. PubMed ID: 4954973
    [No Abstract]   [Full Text] [Related]  

  • 50. [ABO and Rh(D) blood groups in populations of the Lagunera region of Mexico (calculation of the incidence of single and double incompatibility between spouses and maternofetal incompatibility)].
    Garza Chapa R; Tobías Chávez R; Cerda Flores RM; Leal Garza CH
    Salud Publica Mex; 1984; 26(2):130-7. PubMed ID: 6427942
    [No Abstract]   [Full Text] [Related]  

  • 51. [Value of immunologic tests in the hemolytic disease of the newborn in ABO incompatibility].
    Kourteva B; Doitchinova N; Chinkov D
    Nouv Rev Fr Hematol; 1968; 8(6):892-4. PubMed ID: 4236876
    [No Abstract]   [Full Text] [Related]  

  • 52. Incidence of maternal Rh immunization by ABO compatible and incompatible pregnancies.
    Ascari WQ; Levine P; Pollack W
    Br Med J; 1969 Feb; 1(5641):399-401. PubMed ID: 4179167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Experiences with phospholipid determinations in amniotic fluid for the prenatal determination of fetal maturity].
    Widmaier G; Liedtke MP
    Zentralbl Gynakol; 1974 Jul; 96(30):933-9. PubMed ID: 4213876
    [No Abstract]   [Full Text] [Related]  

  • 54. [Feto-maternal conflict in the ABO, Rh and HL-A systems. 3. Incidence of premature labors].
    Zdebski Z
    Ginekol Pol; 1973 Dec; 44(12):1371-6. PubMed ID: 4203134
    [No Abstract]   [Full Text] [Related]  

  • 55. Rhesus and other blood group incompatibilities in pregnancy.
    Gunston KD; Botha I
    S Afr Med J; 1980 Oct; 58(16):639-41. PubMed ID: 6775377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical significance of free and bound Rh antibodies in Rh (c) hemolytic disease of the newborn].
    Spasova K; Vulcheva B; Purvanova Z
    Akush Ginekol (Sofiia); 1979; 18(1):17-9. PubMed ID: 107823
    [No Abstract]   [Full Text] [Related]  

  • 57. [Genetic aspects of the serological conflict in hemolytic disease of the newborn].
    Smirnova GD
    Pediatr Akus Ginekol; 1978; (5):7-8. PubMed ID: 101959
    [No Abstract]   [Full Text] [Related]  

  • 58. [Behavior of incomplete antibodies in Rh sensitized women following surgical and sponateous delivery. (Contribution to the problem of primary resection in Rh incompatibility)].
    Haering M; Pothmann FJ
    Geburtshilfe Frauenheilkd; 1967 Sep; 27(9):894-9. PubMed ID: 4969210
    [No Abstract]   [Full Text] [Related]  

  • 59. [Prognosis of Rh-conflict pregnancy by determining the thermostable alkaline phosphatase activity in the women's blood serum].
    Benediktov AB; Zhantieva EM; Sidel'nikova VM
    Akush Ginekol (Mosk); 1977 Mar; (3):19-21. PubMed ID: 409305
    [No Abstract]   [Full Text] [Related]  

  • 60. [Anti-D-prevention within the scope of a regional work-community].
    Luboldt W; Lohmeyer H; Schmolling E; Hoize J; Neumann H
    Med Klin; 1970 May; 65(22):1082-8. PubMed ID: 5000118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.